- US12600730utility2026Substituted Cyclopenta[c]pyrroles as ABHD6 Antagonists0 cites
- US12497377utility2025Tricyclic Spiro Compound0 cites
- US12459890utility2025Salt and Crystal Form of Compound Having Agonistic Activity to S1P5 Receptor0 cites
- US12447150utility2025Treatment of Cancer by Combination of Immune Checkpoint Inhibitor and Folfirinox Therapy0 cites
- US12325746utility2025Bispecific Antibody0 cites
- US12269817utility2025Compound Having KDM5 Inhibitory Activity and Pharmaceutical Use Thereof0 cites
- US12258308utility2025Benzene Derivative0 cites
- US12201603utility2025Bicyclic Compound and Use Thereof for Medical Purposes0 cites
- US12152049utility2024STING Agonistic Compound0 cites
- US12122846utility2024Chimeric Antigen Receptor for Tumor Targeting0 cites
- US12091461utility2024Bispecific Antibody0 cites
- US12049445utility2024Compounds Having S1P5 Receptor Agonistic Activity0 cites
- US12036204utility2024Pharmaceutical Composition for Treating Tumor0 cites
- US11981682utility2024Substituted Cyclopenta[c]pyrroles as ABHD6 Antagonists0 cites
- US11919917utility2024Sting Agonistic Compound0 cites
- US11897885utility2024Purinone Derivative Hydrochloride0 cites
- US11691968utility2023Compound Having KDM5 Inhibitory Activity and Pharmaceutical Use Thereof0 cites
- US11638744utility2023Immunity Enhancing Agent for Cancer by Allergin-1 Antagonist0 cites
- US11617733utility2023Bicyclic Compound and Use Thereof for Medical Purposes0 cites
- US11566027utility2023Dihydroindolizinone Derivative0 cites
Page 1 of 2Next →